Abstract

Objectives: The aim of the current study was to assess the injection of autologous blood versus the dextrose prolotherapy for the treatment of TMJ hypermobility.Material & methods: This study was conducted on 30 patients who had TMJ subluxation. Patients were divided into 2 equal groups. Group A: 15 patients received autologous blood injection, and Group B: 15 patients received dextrose prolotherapy. Clinical evaluation was performed through Visual Analogue Scale (VAS) to assess patients’ pain preoperatively, at 2 weeks, 1, 3, and 6 months postoperatively. Painless maximum interincisal opening (MIO) was measured preoperatively, 2 weeks, and 3, 6 months postoperatively. Statistical analysis of data was performed.Results: Group B showed a significant (p≤0.001) higher MIO values compared to Group A for all follow-up intervals. There was Significant (p≤0.001) reduction in VAS scores at 2 weeks postoperatively in group A. While, the reduction in VAS at 2 weeks was non-significant (p≥0.001) in group B, but at 1 months postoperatively VAS started to show significant (p≤0.001) reduction. Conclusion: autologous blood injection was superior to dextrose prolotherapy regarding the number of injections needed, pain improvement, and maximal interincisal opening reduction.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call